AzTrials
AzTrials

DyslexiaMFNT-CDYSNCT05949346

Multiple Family Narrative Therapy for Chinese Families of Children With Dyslexia

A study testing Multiple Family Narrative Therapy (MFNT) and School services for families of children with Dyslexia in people with Dyslexia and Special Education, run by Hong Kong Baptist University at 1 site in Hong Kong.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of this randomized controlled trial (RCT) is to develop and to implement a multiple family narrative therapy (MFNT) intervention consisting of parent-child relationships training among Chinese families of children with Dyslexia (CFCDs). Read more about this study

Who is it for?
Ages 7 to 13 years
What is being tested?
Multiple Family Narrative Therapy (MFNT) and School services for families of children with Dyslexia
Could I receive a placebo?
No, everyone receives an active treatment
How many people
123 participants
Where
1 siteHong Kong
Study dates
1 Jan 2022to 6 May 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Participants 7-13 years old and their parents
  • Dyslexia diagnosis (by psychiatrist or educational psychologist or clinical psychologist)
  • Diagnosis with comorbidity of other learning disabilities
  • Cantonese speaking participants (child and parents)
  • At least one of the parents, but not siblings nor grandparents, can commit to all four sessions
  • Participants able to comply with all testing and study requirements

Who cannot join

  • Formal current diagnosis of psychosis
  • Limitation in daily communication
  • Previous service recipients of Narrative Therapy or Multiple Family Group
  • Non-Cantonese speaking child or parent
  • Parents or children who refuse to give written consent for their participation in the study

Trial locations and contacts

1 site in 1 country.

Hong Kong1 site
  • Department of Social Work, Hong Kong Baptist University, Hong Kong, China

    Hong Kong

Other trials in Hong Kong

About this study

Official title: Treatment Efficacy of Multiple Family Narrative Therapy for Chinese Families of Children With Dyslexia: a Randomized Controlled Trial

The goal of this randomized controlled trial (RCT) is to develop and to implement a multiple family narrative therapy (MFNT) intervention consisting of parent-child relationships training among Chinese families of children with Dyslexia (CFCDs). The intervention aims to reduce the psychological distress of parents and their child, thus improving parent-child relationships, and the trial aims to assess the effectiveness of MFNT among them. A RCT design supplemented by qualitative interviews will be used to evaluate the effectiveness of MFNT on family welfare.

Read the detailed description

Dyslexia is a learning disability that causes problems with reading, writing, sequential learning, and phonological processing. It is a diagnosable disorder that commonly coexist with attention-deficit and hyperactivity disorder (ADHD). The estimated percentage of dyslexia in Hong Kong ranges from 9.7 to 12.6%. From 2016 to 2019, the number of students with special learning difficulties in both primary and secondary schools increased by 8.3%. These current statistics project that the number of children with dyslexia will continue to rise in the near future.

International studies indicated that dyslexia impacts the whole family. There are three common problems experienced by families of children with dyslexia: 1) problematic parent-child relationship; 2) parental and psychological distress; and 3) lack of social support. Statistics in Hong Kong also show that Chinese families of children with dyslexia experience similar problems. With daily academic demands, parents are constantly looking for effective ways to manage problems faced by their children with dyslexia even though they do not fully understand their child's dyslexia conditions. In Hong Kong, few studies of psychoeducational models have focused on parent-child relationships, parental stress, and social support for families of children with learning disabilities. The psychological approaches mainly address the behavioural changes of children with Special Educational Needs (SEN). To offset this research gap, it is important to adopt a psychoeducational model and evaluate the effects of the model's intervention on both parents and their children with SEN.

This study addresses a need in the Hong Kong Chinese community and has four expected outcomes: 1) it tests the effectiveness of Multiple Family Narrative Therapy (MFNT) as a brief-targeted intervention model; 2) it facilitates a participatory approach that engages both parents and children; 3) it designs a practice manual that is culturally applicable in the Chinese context; and 4) it encourages the use of the practice manual that outlines a tested model in school and integrative family services.

This study is an evidence-informed and knowledge-building study that aims to test the effectiveness of a brief-targeted MFNT integrative family therapy in Hong Kong compared to a "Treatment as Usual" school-focused approach to work with Chinese family of children with Dyslexia (CFCDs). This approach will target the importance of shifting from academic achievement driven approach, which intensify conflictual parent-child relationship to a collaborative model where family members can review one's identity and re-choose the pattern of interaction among the family members.

The first objective of this study is to test the effectiveness of a brief-targeted Multiple Family Narrative Therapy (MFNT) for Chinese families of children with dyslexia (CFCDs) in Hong Kong, in reducing psychological distress of parents and children, building healthy parent-child relationships, and promoting the use of social support. The second objective is to examine the process of change in attitudes and interactions among family members participating in MFNT.

Being tested
Multiple Family Narrative Therapy (MFNT), School services for families of children with Dyslexia
Keywords
Dyslexia, Narrative therapy, Efficacy, Intervention, Multiple family group, Parent-child, Special educational needs
Medical subject headings
Dyslexia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Multiple Family Narrative Therapy (MFNT)Behavioural

    MFNT consist of 4 weekly group sessions with selected themes from both multiple family therapy (MFT) and narrative therapy (NT) offered in a group format. The family is treated as a system through both psychodynamic practices and attachment theories to manage symptoms, to achieve family resilience, and to empower both parents and child to share their unique and lived value-driven experiences. MFNT provides families with therapeutic environments that are conducive to learning and modelling in order to facilitate the process of building healthier parent-child dyads.

  • School services for families of children with DyslexiaBehavioural

    Selected school personnel will deliver services as usual for the control group.

Study groups in NCT05949346
Study groupRoleWhat they receive
MFNT Intervention (Treatment Group)ExperimentalParents of children with dyslexia who are randomized in Treatment Group will first take part in a pre-tested 4-session MFNT intervention programme. The parents will participate in lectures, group discussions, video demonstrations, and in-group exercises offered in these four mentored sessions, while their children will attend the second and fourth sessions.
Receives: Behavioral: Multiple Family Narrative Therapy (MFNT)
MFNT Intervention (Wait Listing Control Group)ExperimentalFamilies of children with dyslexia who are randomized in Wait Listing Control Group receive services as usual by the school personnel during the intervention period. The 4-session MFNT intervention program will be delivered to them after the intervention period.
Receives: Behavioral: School services for families of children with Dyslexia

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Kessler Psychological Distress Scale (KPDS)

    Kessler Psychological Distress Scale is a 10-item scale completed by the child and the child's parent. It assesses the frequency of distress-related feelings in the past month on a 5-point Likert Scale (1=None of the time; 2=A little of the time; 3=Some of the time; 4=Most of the time; 5=All of the time). The scale is reliable and valid for the local context, given it will be delivered in Chinese. Changes in scores of Kessler Psychological Distress Scale will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

  2. Parental Stress Scale (PSS)

    Parental Stress Scale (PSS) consists of 17 items on a 6-point scale (1 = strongly disagree; 2 = disagree; 3= somewhat disagree; 4 = somewhat agree; 5 = agree; 6 = strongly agree) measuring parents' perception of parental stress. Seven items require reverse scoring. A total score is calculated, with higher scores indicating higher levels of parental stress. The Chinese version of the scale has been translated and validated. Changes in its total score will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

  3. Parent-Child Relationship Scale

    Parent-Child Relationship Scale is a scale that assesses subjects' perceptions of their current relationship with their children. It consists of 17 items based on 5-point scale, ranging from 1 = never to 5 = always. The scale uses mean score, and a higher score indicates a more positive parent-child relationship. Changes in its mean score will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

  4. Parental Bonding Inventory (PBI)

    Parental Bonding Inventory (PBI) is a 25-item instrument assessing levels of parental care and overprotection perceived by the child. It consisted of two subscales termed 'care' and 'overprotection/control'. The measure is to be completed for both mothers and fathers separately, with each parent being scored on a 4-point Likert scale (Very unlike = 0, Moderately unlike = 1, Moderately like = 2, Very like = 3). Changes in the scores in "care" and "overprotection/control" subscales in both father and mother will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

Secondary outcomes (2)
  1. Satisfaction With Family Life Scale (SWFL)

    Satisfaction With Family Life Scale (SWFL) is a 5-item scale that assesses an individual's global judgment of family satisfaction. Parents and children were required to agree or disagree with global statements about family life on a 7-point Likert-type scale ranging from 1 = strongly disagree to 7 = strongly agree. This instrument has been successfully used in a variety of family samples and offers a brief, widely applicable tool to measure satisfaction with family life. Changes in its total score will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

  2. Guilt and Shame Questionnaire (GSQ)

    Guilt and Shame Questionnaire (GSQ) is a 10-item scale to assess one's feelings of guilt and shame associated with disabilities including but not limited to mental illness. It consisted of two subscale - shame and guilt, both are rated on a 5-point Likert scale ranging from 1 (never) to 5 (always). The scale was completed by parents and children. The evaluation of guilt and shame is calculated based on the sum scores of each subscale. Changes in scores of total scale, guilt and shame subscales will be evaluated before, after the intervention as well as at a follow-up assessment (3 months after the end of the intervention).

    Measured: 1 week prior intervention, Intervention week 4, and 3 months post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2023
  2. Study start1 Jan 2022
  3. Primary completion6 May 2023
  4. Study completion6 May 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
123 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05949346
Sponsor's protocol ID
RGC Ref No. 12607921
Other IDs
General Research Fund (GRF)
Acronym
MFNT-CDYS
Status last verified
Mar 2021
First submitted
9 Jul 2023
Last updated
18 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Multiple Family Narrative Therapy (MFNT) and School services for families of children with Dyslexia in people with Dyslexia and Special Education, run by Hong Kong Baptist University at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Kessler Psychological Distress Scale (KPDS) (time frame: 1 week prior intervention, Intervention week 4, and 3 months post-intervention). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Jul 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in